Skip to main content

$0.075 (0%)

High

-

Low

-

Trades

-

Turnover

$0

Volume

0
15 June 2026 at 7:35pm
Register to track PAA and receive email alerts.

Key Appointment to Progress MPL COVID-19 Clinical Trial

StockBot

416,823 posts

PAA released this announcement to the ASX on 21 February 2022, 8:04. The announcement is marked as price sensitive, and is 2 page(s) in length and 316.4kb in size.

You can view all announcements from PAA and see how they appear on a price chart on the announcements page.

At the date of this announcement, PAA was 0.072% short sold according to ASIC data. It was ranked the 487th most shorted stock on the ASX. It remains ranked 492nd as of the latest reported data (11 October 2024).

Other Recent Announcements from PAA
Results of General Meeting 30 June 2023, 12:38
Trading Halt 30 June 2023, 9:48
General Meeting - Chairman Script 30 June 2023, 9:42
Key Appointment to Progress MPL COVID-19 Clinical Trial 21 February 2022, 8:04
Appendix 4D & Half Year Report 18 February 2022, 17:53
Epichem Confirms Effectiveness of OHD E-Waste Project 16 February 2022, 8:10
Resignation of Epichem CEO 3 February 2022, 11:36
You must login or register to post a comment.

You must be logged in to post a reply.

Register to track PAA and receive email alerts.